Consultant-led education CPD accredited
Current pitfalls in HSCT: Managing anicteric VOD and the impact of COVID-19 on local practice
In this webinar, Prof. Antonio Pagliuca starts by discussing the impact of COVID-19 on clinical practice at King’s College Hospital. Prof. Selim Corbacioglu then talks about the importance of recognising anicteric VOD in adults and children alike. Finally, Prof. Pagliuca presents a case study of a patient with anicteric VOD.
Case studies Diagnosis and severity grading Risk assessment and monitoring Treatment
ADVERSE EVENTS REPORTING
Adverse events should be reported. Reporting forms and information for the UK can be found at: https://yellowcard.mhra.gov.uk/
For Ireland, reporting forms and information can be found at: www.hpra.ie
Adverse events should also be reported to Jazz Pharmaceuticals at: AEreporting@jazzpharma.com
Defitelio® is indicated for the treatment of severe hepatic veno-occlusive disease (VOD) also known as sinusoidal obstruction syndrome (SOS) in haematopoietic stem-cell transplantation (HSCT) therapy. It is indicated in adults and in adolescents, children and infants over 1 month of age.